Moneycontrol
Jan 13, 2017 01:14 PM IST | Source: Moneycontrol.com

Sun Pharma Q3 PAT may dip 26.2% to Rs 1649.5 cr: KR Choksey

Net Sales are expected to decrease by 3 percent Q-o-Q (up 6.9 percent Y-o-Y) to Rs 7529.4 crore, according to KR Choksey.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

KR Choksey has come out with its third quarter (October-December) earnings estimates for the Pharma sector. The brokerage house expects Sun Pharma to report net profit at 1649.5 crore down 26.2% quarter-on-quarter.


Net Sales are expected to decrease by 3 percent Q-o-Q (up 6.9 percent Y-o-Y) to Rs 7529.4 crore, according to KR Choksey.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 19.6 percent Q-o-Q (up 17.4 percent Y-o-Y) to Rs 2546.5 crore.

Disclaimer:
The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Sections
Follow us on
Available On